ClinVar Miner

Submissions for variant NM_000546.6(TP53):c.86_96+4del

dbSNP: rs1555526916
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 1
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Ambry Genetics RCV000492216 SCV000581117 pathogenic Hereditary cancer-predisposing syndrome 2023-12-05 criteria provided, single submitter clinical testing The c.86_96+4del15 pathogenic mutation results from a deletion of 15 nucleotides spanning the last 11 nucleotides of coding exon 2 through the first 4 nucleotides after coding exon 2 in the TP53 gene. In silico splice site analysis predicts that this alteration will weaken the native splice donor site. This variant is considered to be rare based on population cohorts in the Genome Aggregation Database (gnomAD). This alteration also causes an out-of-frame deletion of 11 nucleotides between positions 86 and 96 within coding exon 2, resulting in a translational frameshift with a predicted alternate stop codon. Alterations that disrupt the canonical splice site are expected to cause aberrant splicing, and frameshifts are expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.